Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world.

Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.

Cardiome Pharma was founded on December 12, 1986 and is headquartered in Vancouver, Canada.
Sales per Businesses
20122013Delta
CAD (in Million)%CAD (in Million)%
Pharmaceutical Product Development0.789100%4.65100% +83.03%
Sales per Regions
2013
CAD (in Million)%
Rest of the World2.6957.9%
Europe1.9542.1%
Managers
NameAgeSinceTitle
William L. Hunter, MD522007President, Chief Executive Officer & Director
Robert W. Rieder, MBA691997Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Jennifer Archibald, CA-2006Chief Financial Officer
Harold H. Shlevin, PhD652004Independent Director
Peter W. Roberts, CPA712005Independent Director
William James O'Shea652014Director
Richard M. Glickman, PhD55-Lead Independent Director
Jürgen Polifka, PhD-2013General Manager-European Sales & Marketing
Karim F. Lalji-2006Chief Commercial Officer
Shareholders
NameShares%
Westfield Capital Management Co. LP 2,236,577 13.3%
Fidelity Management & Research Co. 1,595,312 9.51%
Putnam Investment Management LLC 1,210,643 7.22%
FIG LLC (Private Equity) 889,344 5.30%
Adage Capital Management LP 600,000 3.58%
Clough Capital Partners LP 512,533 3.06%
William L. Hunter, MD 510,000 3.04%
AlphaOne Investment Services LLC 312,684 1.86%
Longwood Capital Partners LLC 303,477 1.81%
PointState Capital LP 250,000 1.49%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
ABBVIE INC
CELGENE CORPORATI..
BIOGEN INC
ASTRAZENECA PLC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
INDIVIOR PLC
CHONGQING ZHIFEI ..
-
CELLDEX THERAPEUT..
WALVAX BIOTECHNOL..
-
THERAVANCE INC
STAIDSON (BEIJING..
-
GREEN CROSS CORP
MEDY TOX INC
AMAG PHARMACEUTIC..
Sector Pharmaceuticals
Cardiome Pharma Corp. : Connections
Michael Smith Foundation for Health Research
BC Advantage Funds (VCC) Ltd.
Canadian Institute of Chartered Accountants
Nventa Biopharmaceuticals Corp.
Canadian Public Accountability Board
Richardson Capital Ltd.
ESSA Pharmaceuticals Inc
Premier's Technology Council
ATDC Seed Capital Fund LLC
MedGenesis Therapeutix, Inc.
Institute of Corporate Directors
Kearny Venture Partners
Trevi Therapeutics, Inc.
The Institute of Electrical & Electronics Engineers, Inc.
ProStrakan Group Plc
Licensing Executives Society
enGene, Inc.
The American Physiological Society
viDA Therapeutics, Inc.
American Society for Pharmacology & Experimental Therapeutic
Beth Israel Deaconess Medical Center, Inc.
Company contact information
Cardiome Pharma Corp.
6190 Agronomy Road
Suite 405
Vancouver, BC V6T 1Z3

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2015 People , Fundamentals and Ownership   
Dynamic quotes  
ON
| OFF